San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

The company plans to discontinue the study after the combination therapy failed to meet the primary endpoint in the Phase III ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...

(RTTNews) - Syndax Pharmaceuticals, Inc. (SNDX), Tuesday announced positive results from the relapsed or refractory mutant NPM1 acute myeloid leukemia cohort in the pivotal Phase 2 portion of the ...

Eight-year-old Florrie Bark, from Corby, Northamptonshire received the Child of Courage award following a battle with acute myeloid leukaemia (AML), an aggressive form of cancer. The family has ...

Dr Stephen Ma – Developing a cancer vaccine against acute myeloid leukaemia With dual haematology (RACP / RCPA) advanced training, Dr Stephen Ma has and worked at several Victorian tertiary centres ...

WHEELING, W.Va. — Govenor Jim Justice joined West Virginia Tourism Secretary Chelsea Ruby and other officials in Wheeling to present a $4.4 million AML Economic Revitalization grant in support ...

Novartis has received US Food and Drug Administration (FDA) accelerated approval for Scemblix (asciminib) to treat adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid ...

Acute myeloid leukemia (AML) is a blood cell cancer that is estimated to cause ∼100,000 deaths worldwide each year. (1) Current standard of care includes treatment with chemotherapeutic agents, newer ...